focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK fraud head expects corporate plea deals, considers Libor charges

Tue, 25th Oct 2016 14:53

* SFO head David Green gives evidence to UK lawmakers

* Green says "significant" new DPAs on horizon

* Green says Serco probe looking at "different conduct"

By Kirstin Ridley

LONDON, Oct 25 (Reuters) - The UK Serious Fraud Office (SFO)expects to agree some "significant" corporate plea deals overthe coming months and is also considering filing more charges inthe Libor benchmark rate rigging investigation, its head said onTuesday.

The SFO's probe into alleged manipulation of benchmark ratessuch as Libor (London interbank offered rate), which began in2012, has so far resulted in five convictions and six acquittalsof individuals. Eight others face trial next year.

SFO director David Green told a parliamentary committee oflawmakers that there were also "some others" who it had todecide whether to charge.

Lawmakers asked whether the SFO had the resources to providea credible threat of prosecution if companies failed to reportthemselves to the authorities when they discover wrongdoing.

Green said he had spent four years speaking at leastfortnightly with businesses and lawyers explaining theincentives behind self-reporting, while building up the agency'sintelligence division.

"You will see over the coming months some significantdeferred prosecution agreements (DPAs)," he said.

DPAs, effective plea deals introduced in Britain in 2014,were a useful tool to encourage good corporate conduct, Greensaid, and were available to those who report wrongdoingpromptly, cooperate, grant authorities access to factualdocuments and assist in prosecuting individuals.

A judge approved Britain's first DPA in November in a casecentred on $6 million in bribes paid to Tanzanian officials bythe Tanzanian unit of South Africa's Standard Bank.

Tesco is among companies cooperating with acriminal inquiry into accounting practices, launched after thesupermarket chain said it overstated half year profits in August2014 by about 260 million pounds ($320 million).

Green also said a new line of inquiry had also been openedin a three-year inquiry into global outsourcing group Serco, launched after an audit alleged the government had beencharged for tagging criminals who were either dead or in prison.

The SFO head gave no further details on the Libor inquiry, aglobal investigation in which it has charged around 20.

Barclays, which has seen 10 former traders chargedfor alleged benchmark rigging and admitted in 2012 tolow-balling, or artificially lowering, rates during the creditcrisis, reiterated in its 2015 annual report that it continuedto respond to information requests as part of an SFO inquiry. (Editing by Alexander Smith)

More News
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.